0001140361-23-054506.txt : 20231122
0001140361-23-054506.hdr.sgml : 20231122
20231122190649
ACCESSION NUMBER: 0001140361-23-054506
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231030
FILED AS OF DATE: 20231122
DATE AS OF CHANGE: 20231122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ma Songjiang
CENTRAL INDEX KEY: 0001985547
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 231434754
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (619) 949-3681
MAIL ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20150820
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
3/A
1
form3.xml
X0206
3/A
2023-10-30
2023-11-01
0
0001124105
GYRE THERAPEUTICS, INC.
GYRE
0001985547
Ma Songjiang
C/O GYRE THERAPEUTICS, INC.
12770 HIGH BLUFF DRIVE, SUITE 150
SAN DIEGO
CA
92130
true
true
President
Common Stock
2942467
I
By Spouse
Represents the number of shares of common stock of the Issuer received by the spouse of the Reporting Person in exchange for the shares of Ratel Holdings Limited, a company incorporated in the British Virgin Islands with limited liability, held by the spouse of the Reporting Person pursuant to that certain Business Combination Agreement, dated as of December 26, 2022 and as amended on March 29, 2023 and August 30, 2023 (the "Business Combination Agreement"), by and among Catalyst Biosciences, Inc., a Delaware corporation, GNI USA, Inc., a Delaware corporation, GNI Group Ltd., a company incorporated under the laws of Japan with limited liability,
[cont'd from FN 1] GNI Hong Kong Limited, a company incorporated under the laws of Hong Kong with limited liability, Shanghai Genomics, Inc., a company organized under the laws of the People's Republic of China, the Minority Holders (as defined therein) and Continent Pharmaceuticals Inc., a Cayman Islands company limited by shares. Pursuant to the terms of the Business Combination Agreement, on October 30, 2023, the Issuer acquired an indirect controlling interest in Beijing Continent Pharmaceuticals Co., Ltd, a company organized under the laws of the People's Republic of China.
These shares were inadvertently omitted from the reporting person's original Form 3.
/s/ Ruoyu Chen, as attorney-in-fact for Songjiang Ma
2023-11-22